The emerging GLP-1 drug retatrutide presents a notable challenge regarding the cost. As of now , the retail price stands around close to $1,400 for each dose, causing it surprisingly expensive for many individuals. Reasons driving this high cost include the sophisticated production process, continuous studies , and the limited supply initially. Ins